Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE

NCT02908217 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT02908217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02908217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE
Lead sponsor
University Hospital, Brest
Phase
Phase 3
Overall status
Completed
Start date
February 15, 2017
Completion date
November 12, 2020
Enrollment
113 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

polymyalgia rheumatica